These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 25670890)

  • 21. Comparison of Resolute zotarolimus-eluting stents versus everolimus-eluting stents in patients with metabolic syndrome and acute myocardial infarction: propensity score-matched analysis.
    Ji MS; Jeong MH; Ahn YK; Kim SH; Kim YJ; Chae SC; Hong TJ; Seong IW; Chae JK; Kim CJ; Cho MC; Rha SW; Bae JH; Seung KB; Park SJ; Hur SH;
    Int J Cardiol; 2015 Nov; 199():53-62. PubMed ID: 26186631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebrovascular events after a primary percutaneous coronary intervention strategy for acute ST-segment-elevation myocardial infarction: analysis from the HORIZONS-AMI Trial.
    Nikolsky E; Mehran R; Dangas GD; Xu K; Parvataneni R; Witzenbichler B; Guagliumi G; Kornowski R; Généreux P; Brener SJ; Stone GW
    Circ Cardiovasc Interv; 2015 Apr; 8(4):. PubMed ID: 25858976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness of a European ST-segment elevation myocardial infarction network: results from the Catalan Codi Infart network.
    Regueiro A; Bosch J; Martín-Yuste V; Rosas A; Faixedas MT; Gómez-Hospital JA; Figueras J; Curós A; Cequier A; Goicolea J; Fernández-Ortiz A; Macaya C; Tresserras R; Pellisé L; Sabaté M
    BMJ Open; 2015 Dec; 5(12):e009148. PubMed ID: 26656019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiologist service volume, percutaneous coronary intervention and hospital level in relation to medical costs and mortality in patients with acute myocardial infarction: a nationwide study.
    Liu CY; Lin YN; Lin CL; Chang YJ; Hsu YH; Tsai WC; Kao CH
    QJM; 2014 Jul; 107(7):557-64. PubMed ID: 24570479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of abciximab on prognosis in diabetic patients undergoing primary percutaneous coronary intervention.
    Perkan A; Vitrella G; Barbati G; De Monte A; D'Agata B; Merlo M; Giannini F; Della Grazia E; Rakar S; Salvi A; Igidbashian D; Morgera T; Zalukar W; Sinagra G
    J Cardiovasc Med (Hagerstown); 2013 Feb; 14(2):127-35. PubMed ID: 22343257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [What aspects are inefficient concerning percutaneous coronary intervention in Japan?: International cost-effectiveness comparisons].
    Chino M; Sakamoto M; Sasaki T; Isshiki T
    J Cardiol; 2004 Sep; 44(3):85-92. PubMed ID: 15500158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends of hospitalizations, fatality rate and costs for acute myocardial infarction among Spanish diabetic adults, 2001-2006.
    Lopez-de-Andres A; Hernández-Barrera V; Carrasco-Garrido P; Esteban-Hernandez J; Gil-de-Miguel A; Jiménez-García R
    BMC Health Serv Res; 2010 Mar; 10():59. PubMed ID: 20205960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of prasugrel versus clopidogrel in patients with acute coronary syndromes and planned percutaneous coronary intervention: results from the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with Prasugrel-Thrombolysis in Myocardial Infarction TRITON-TIMI 38.
    Mahoney EM; Wang K; Arnold SV; Proskorovsky I; Wiviott S; Antman E; Braunwald E; Cohen DJ
    Circulation; 2010 Jan; 121(1):71-9. PubMed ID: 20026770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of streptokinase for acute myocardial infarction: A combined meta-analysis and decision analysis of the effects of infarct location and of likelihood of infarction.
    Midgette AS; Wong JB; Beshansky JR; Porath A; Fleming C; Pauker SG
    Med Decis Making; 1994; 14(2):108-17. PubMed ID: 8028463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changing practice patterns in the management of acute myocardial infarction complicated by cardiogenic shock: elderly compared with younger patients.
    Dzavík V; Burton JR; Kee C; Teo KK; Ignaszewski A; Lucas AR; Tymchak WJ
    Can J Cardiol; 1998 Jul; 14(7):923-30. PubMed ID: 9706277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Percutaneous cardiac assist devices compared with surgical hemodynamic support alternatives: cost-effectiveness in the emergent setting.
    Maini B; Gregory D; Scotti DJ; Buyantseva L
    Catheter Cardiovasc Interv; 2014 May; 83(6):E183-92. PubMed ID: 24130115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute myocardial infarction: clinical characteristics, management and outcome in a university medical centre in a developing Middle Eastern country.
    Dakik HA; Koubeissi Z; Kleiman NS; Nasrallah A; Sawaya J; Gharzuddine W; Tamim H; Shaar K; Alam S
    Can J Cardiol; 2004 Jun; 20(8):789-93. PubMed ID: 15229760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical characteristics and risk assessment of ST-segment elevation myocardial infarction patients of an Iranian referral center.
    Khalili H; Talasaz AH; Jenab Y; Salarifar M
    J Cardiovasc Med (Hagerstown); 2012 Nov; 13(11):708-15. PubMed ID: 22914305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin D and prognosis in acute myocardial infarction.
    Ng LL; Sandhu JK; Squire IB; Davies JE; Jones DJ
    Int J Cardiol; 2013 Oct; 168(3):2341-6. PubMed ID: 23415169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of Outcomes of Patients With Sepsis With Versus Without Acute Myocardial Infarction and Comparison of Invasive Versus Noninvasive Management of the Patients With Infarction.
    Smilowitz NR; Gupta N; Guo Y; Bangalore S
    Am J Cardiol; 2016 Apr; 117(7):1065-71. PubMed ID: 26853952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence and outcomes of no-reflow phenomenon during percutaneous coronary intervention among patients with acute myocardial infarction.
    Harrison RW; Aggarwal A; Ou FS; Klein LW; Rumsfeld JS; Roe MT; Wang TY;
    Am J Cardiol; 2013 Jan; 111(2):178-84. PubMed ID: 23111142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pathogenic factors and prognosis of non cardiac inpatients with acute myocardial infarction].
    Cao MY; Yao ZH; Zhou X; Zheng QX; Cai HB
    Zhonghua Yi Xue Za Zhi; 2013 May; 93(19):1463-8. PubMed ID: 24029568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient classification and hospital costs of care for acute myocardial infarction in nine European countries.
    Häkkinen U; Chiarello P; Cots F; Peltola M; Rättö H;
    Health Econ; 2012 Aug; 21 Suppl 2():19-29. PubMed ID: 22815109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of Post-TKA Acute Myocardial Infarction in Patients With a History of Myocardial Infarction or Coronary Stent.
    Kumar A; Tsai WC; Tan TS; Chiu LT; Kung PT; Lo CK; Ku MC
    Clin Orthop Relat Res; 2016 Feb; 474(2):479-86. PubMed ID: 26566978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of free universal medical coverage on medical care and outcomes in low-income patients hospitalized for acute myocardial infarction: an analysis from the FrenchNational Health Insurance system.
    Danchin N; Neumann A; Tuppin P; De Peretti C; Weill A; Ricordeau P; Allemand H
    Circ Cardiovasc Qual Outcomes; 2011 Nov; 4(6):619-25. PubMed ID: 21972406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.